The briefing
Aurobindo Pharma reported strong first-quarter earnings on broad-based revenue growth, lifting net profit to ₹1,032 crore. The board also cleared the merger of three subsidiaries to streamline operations and support future expansion.
Original headline
Aurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms